Objetivo Non-invasive, inexpensive, and accurate assessment of adipose tissue (BAT) activity is crucial in the fight against metabolic pandemics such as obesity, and in various industries (e.g. foods, pharmaceuticals). However, the only technique available to measure the activity of this tissue is PET/CT imaging of the glucosetracer 18F-fluorodeoxyglucose , a highly invasive technique that is harmful for human health, expensive, and requires extensive equipment and facilities. The development and validation of non-invasive and practical techniques to accurately estimate human BAT activity requires the creation of new technology and the advancement of the current state of the art. Companies (particularly SMEs) do not have the technical capabilities to conduct R&D activities at the level of excellence required for such development. Academic institutions have the capacity to conduct the necessary R&D but they lack the expertise to develop the prototype post project. To solve this intersectoral problem, the ICI-THROUGH project will create a sustainable innovation platform of intersectoral collaboration between two academic (UOT and UOP) and two industrial (IMED and CETRI) European participants to exchange knowledge on the development of non-invasive techniques to estimate human BAT activity. This will be achieved via a series of clear and measurable research and innovation objectives that will be realized via staff exchanges of experienced and early-stage researchers divided into: networking, research and training, workshop, innovation, dissemination, and public engagement activities. The ICI-THROUGH project is effectively aligned with the scope of the RISE call and its success is in the interest of all participants. Also, exploitation of the obtained tangible outcomes (e.g. prototype) will ensure the partnership’s sustainability post project. Thus, the ICI-THROUGH project has high potential to become a self-sustaining innovation incubator between the four participants. Ámbito científico medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsmedical and health scienceshealth sciencespublic healthepidemiologypandemicsmedical and health sciencesclinical medicineendocrinologydiabetesmedical and health sciencesclinical medicinecardiologycardiovascular diseasesmedical and health scienceshealth sciencesnutritionobesity Programa(s) H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme H2020-EU.1.3.3. - Stimulating innovation by means of cross-fertilisation of knowledge Tema(s) MSCA-RISE-2014 - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) Convocatoria de propuestas H2020-MSCA-RISE-2014 Consulte otros proyectos de esta convocatoria Régimen de financiación MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE) Coordinador PANEPISTIMIO THESSALIAS Aportación neta de la UEn € 207 000,00 Dirección ARGONAFTON FILELLINON 38221 Volos Grecia Ver en el mapa Región Κεντρική Ελλάδα Θεσσαλία Μαγνησία Tipo de actividad Higher or Secondary Education Establishments Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 207 000,00 Participantes (3) Ordenar alfabéticamente Ordenar por aportación neta de la UE Ampliar todo Contraer todo UNIVERSIDADE DO PORTO Portugal Aportación neta de la UEn € 207 000,00 Dirección PRACA GOMES TEIXEIRA 4099-002 Porto Ver en el mapa Región Continente Norte Área Metropolitana do Porto Tipo de actividad Higher or Secondary Education Establishments Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 207 000,00 IMEDICA SA Rumanía Aportación neta de la UEn € 207 000,00 Dirección STRADA SOS BUCURESTI PLOIESTI 141D 013686 BUCARESTI Ver en el mapa Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí Región Macroregiunea Trei Bucureşti-Ilfov Bucureşti Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 207 000,00 CENTER FOR TECHNOLOGY RESEARCH ANDINNOVATION (CETRI) LTD Chipre Aportación neta de la UEn € 207 000,00 Dirección 77, John Kennedy Avenue 1077 Nicosia Ver en el mapa Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí Región Κύπρος Κύπρος Κύπρος Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Enlaces Contactar con la organización Opens in new window Sitio web Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 207 000,00
